Vice President of Research & Development
Ariadne Diagnostics, LLC
Email - Michael S
Dr. Lebowitz has over 22 years research experience in the biomedical sciences including 12 years involved in the development of cancer biomarkers for diagnostic testing. Prior to joining Ariadne Diagnostics, Dr. Lebowitz was the Director of R & D at 20/20 GeneSystems, Inc. where he oversaw the development and launch of a blood test for the early diagnosis of lung cancer and was involved in platform development and biomarker discovery for several companion diagnistics tests for kidney and breast cancers, Dr. Lebowitz was formerly the Director of Research at Panacea Pharmaceuticals, Inc. where he was instrumental in the formation of an in-house CLIA-approved laboratory and the launch of three immunoassays for the early detection of cancer and one companion diagnostic; a gene expression-based test to predict the efficacy of a molecular-targeted therapy. He has experience working with diagnostic regulatory submissions and the FDA.
Dr. Lebowitz was trained at Johns Hopkins University, School of Medicine where he did graduate work in biochemistry, cellular and molecular biology and postdoctoral work in immunopathology.